Inventor
WIDDER KENNETH J
US37 patents
⚠️ This page may combine multiple inventors who share the name “WIDDER KENNETH J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYDNEXIS INC
19 patentsUS9770447B2Sep 26, 2017
Ophthalmic composition
SYDNEXIS INC21 citations97
US9421199B2Aug 23, 2016
Ophthalmic composition
SYDNEXIS INC45 citations97
US11596625B2Mar 7, 2023
Ophthalmic composition
SYDNEXIS INC9 citations94
US10953002B2Mar 23, 2021
Ophthalmic composition
SYDNEXIS INC11 citations94
US10940145B2Mar 9, 2021
Ophthalmic composition
SYDNEXIS INC19 citations94
US10888557B2Jan 12, 2021
Ophthalmic composition
SYDNEXIS INC20 citations94
US10842787B2Nov 24, 2020
Ophthalmic composition
SYDNEXIS INC15 citations94
US10813923B1Oct 27, 2020
Ophthalmic composition
SYDNEXIS INC11 citations94
US10201534B2Feb 12, 2019
Ophthalmic composition
SYDNEXIS INC19 citations94
US10864208B2Dec 15, 2020
Ophthalmic composition
SYDNEXIS INC7 citations92
US10076515B2Sep 18, 2018
Ophthalmic Composition
SYDNEXIS INC16 citations92
US11896588B2Feb 13, 2024
Ophthalmic composition
SYDNEXIS INC2 citations84
US11382909B2Jul 12, 2022
Ophthalmic composition
SYDNEXIS INC4 citations84
US11052095B2Jul 6, 2021
D2O stabilized pharmaceutical formulations
SYDNEXIS INC7 citations84
US11052094B2Jul 6, 2021
D2O stabilized pharmaceutical formulations
SYDNEXIS INC8 citations84
US12070466B2Aug 27, 2024
D2O stabilized pharmaceutical formulations
SYDNEXIS INC1 citations73
US11890277B2Feb 6, 2024
Ophthalmic composition
SYDNEXIS INC1 citations73
US11883390B2Jan 30, 2024
Ophthalmic composition
SYDNEXIS INC1 citations73
US12168017B2Dec 17, 2024
D2O stabilized pharmaceutical formulations
SYDNEXIS INC0 citations62
MOLECULAR BIOSYSTEMS INC
13 patentsUS5315997AMay 31, 1994
Method of magnetic resonance imaging using diamagnetic contrast
MOLECULAR BIOSYSTEMS INC159 citations98
US5716597AFeb 10, 1998
Emulsions as contrast agents and method of use
MOLECULAR BIOSYSTEMS INC102 citations96
US5536489AJul 16, 1996
Emulsions as contrast agents and method of use
MOLECULAR BIOSYSTEMS INC206 citations96
US4849210AJul 18, 1989
Magnetic resonance imaging of liver and spleen with superparamagnetic contrast agents
MOLECULAR BIOSYSTEMS INC65 citations96
US4844882AJul 4, 1989
Concentrated stabilized microbubble-type ultrasonic imaging agent
MOLECULAR BIOSYSTEMS INC356 citations96
US4675173AJun 23, 1987
Method of magnetic resonance imaging of the liver and spleen
MOLECULAR BIOSYSTEMS INC116 citations96
US5732707AMar 31, 1998
Method of ultrasonically quantitating myocardial perfusion using as intravenously injected tracer
MOLECULAR BIOSYSTEMS INC211 citations94
US5611342AMar 18, 1997
Method of computer tomography imaging the gastrointestinal tract and surrounding upper abdominal tissues and organs using an orally administered low density contrast medium
MOLECULAR BIOSYSTEMS INC20 citations93
US5107842AApr 28, 1992
Method of ultrasound imaging of the gastrointestinal tract
MOLECULAR BIOSYSTEMS INC115 citations92
US5179955AJan 19, 1993
Method of abdominal ultrasound imaging
MOLECULAR BIOSYSTEMS INC32 citations91
US5385147AJan 31, 1995
Method of ultrasonic imaging of the gastrointestinal tract and upper abdominal organs using an orally administered negative contrast medium
MOLECULAR BIOSYSTEMS INC34 citations89
US5373846ADec 20, 1994
Method of ultrasonic imaging of body cavities
MOLECULAR BIOSYSTEMS INC14 citations74
US6030603AFeb 29, 2000
Emulsions as contrast agents and method of use
MOLECULAR BIOSYSTEMS INC4 citations60
UNIV NORTHWESTERN
3 patentsUS4345588AAug 24, 1982
Method of delivering a therapeutic agent to a target capillary bed
UNIV NORTHWESTERN286 citations99
US4230685AOct 28, 1980
Method of magnetic separation of cells and the like, and microspheres for use therein
UNIV NORTHWESTERN278 citations99
US4357259ANov 2, 1982
Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
UNIV NORTHWESTERN131 citations96